Q3 FY2026 · ended Sep 30, 2026 · Revenue $132.08M, -1.8% YoY · Filed Oct 30, 2026
Core Laboratories Inc. (CLB) files with the SEC under industry code 1389, Oil & Gas Field Services, NEC. In Q3 of fiscal 2026, the quarter ended Sep 30, 2026, it reported revenue of $132.1 million and net income of $5.4 million. Free cash flow was $1.7 million. As of Sep 30, 2026 it held $21.4 million in cash and investments and $164.3 million in total debt.
Revenue
$132.08M
-1.8% vs year-ago quarter
Net income
$5.44M
-61.8% vs year-ago quarter
Operating cash flow
$4.97M
-41.6% vs year-ago quarter
Free cash flow
$1.72M
-73.5% vs year-ago quarter
EPS
$0.12
-60.0% vs year-ago quarter
Dividend per share
$0.01
+0.0% vs year-ago quarter
Shares outstanding
45.82M
-1.6% vs year-ago quarter
Net cash
$-142.90M
Q3 FY2026
Operating margin
7.5%
TTM
Company profile
- Industry
- Oil & Gas Field Services, NEC (SIC 1389)
- Listed as
- CLB (NYSE)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Houston, TX
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1958086
- Former names
- Core Laboratories Luxembourg S.A. (until Feb 28, 2023)
Other Oil & Gas Field Services, NEC companies
Key figures
Fiscal-year totals from the annual reports; switch to Annual for the full-year view. Balance sheet lines are as of each year end.
| Line | Q3 FY2026 Sep 30, 2026 |
Q2 FY2026 Jun 30, 2026 |
Q1 FY2026 Mar 31, 2026 |
Q4 FY2025 Dec 31, 2025 |
Q3 FY2025 Sep 30, 2025 |
|---|---|---|---|---|---|
| Revenue | $132.1M | $124.6M | $121.8M | $138.3M | $134.5M |
| Operating income | $12.1M | $9.2M | $1.9M | $15.8M | $20.9M |
| Net income | $5.4M | $6.0M | -$789,000 | $4.9M | $14.2M |
| Diluted EPS | $0.12 | $0.13 | -$0.02 | $0.11 | $0.30 |
| Operating cash flow | $5.0M | $7.8M | $4.0M | $7.9M | $8.5M |
| Free cash flow | $1.7M | $3.1M | $517,000 | $5.0M | $6.5M |
| Total assets | $593.5M | $586.8M | $587.7M | $584.0M | $586.1M |
| Stockholders' equity | $278.0M | $272.7M | $268.9M | $266.0M | $271.3M |
| Cash and investments | $21.4M | $22.7M | $22.8M | $22.7M | $25.6M |
| Total debt | $164.3M | $167.6M | $170.4M | $166.8M | $170.0M |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Oct 30, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Oct 28, 2026 | Oct 28, 2026 |
| 8-K |
Current report
Officer or director change
|
Aug 25, 2026 | Aug 19, 2026 |
| 10-Q | Quarterly report | Jul 30, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Jul 29, 2026 | Jul 29, 2026 |
| 8-K |
Current report
Shareholder vote results
|
May 13, 2026 | May 12, 2026 |
All 186 Core Laboratories Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.